A Multinational, Randomised, Double-blind, Placebo-controlled, Phase III Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer

Type of Cancer
Genito-Urinary

Site
Hackensack

Sponsor
Bayer

Protocol Number
Bayer 17712

To Learn More Call
201-510-0910